<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:58:02Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9169327" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9169327</identifier>
        <datestamp>2022-06-07</datestamp>
        <setSpec>bmcmedicine</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Med</journal-id>
              <journal-title-group>
                <journal-title>BMC Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1741-7015</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9169327</article-id>
              <article-id pub-id-type="pmcid">PMC9169327</article-id>
              <article-id pub-id-type="pmc-uid">9169327</article-id>
              <article-id pub-id-type="pmid">35658861</article-id>
              <article-id pub-id-type="publisher-id">2400</article-id>
              <article-id pub-id-type="doi">10.1186/s12916-022-02400-6</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>You</surname>
                    <given-names>Dongfang</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Danhua</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Wu</surname>
                    <given-names>Yaqian</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Xin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shao</surname>
                    <given-names>Fang</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wei</surname>
                    <given-names>Yongyue</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Ruyang</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lange</surname>
                    <given-names>Theis</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ma</surname>
                    <given-names>Hongxia</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Xu</surname>
                    <given-names>Hongyang</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hu</surname>
                    <given-names>Zhibin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Christiani</surname>
                    <given-names>David C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shen</surname>
                    <given-names>Hongbing</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Feng</given-names>
                  </name>
                  <address>
                    <email>fengchen@njmu.edu.cn</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Zhao</surname>
                    <given-names>Yang</given-names>
                  </name>
                  <address>
                    <email>yzhao@njmu.edu.cn</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Department of Biostatistics, School of Public Health, </institution><institution>Nanjing Medical University, </institution></institution-wrap>101 Longmian Avenue, Nanjing, 211166 Jiangsu China </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Environmental Health, </institution><institution>Harvard T.H. Chan School of Public Health, </institution></institution-wrap>Boston, MA 02115 USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Department of Public Health and Preventive Medicine, </institution><institution>Kangda College of Nanjing Medical University, </institution></institution-wrap>Lianyungang, 222000 China </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>China International Cooperation Center for Environment and Human Health, Center for Global Health, </institution><institution>Nanjing Medical University, </institution></institution-wrap>Nanjing, 211166 Jiangsu China </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>The Center of Biomedical Big Data and the Laboratory of Biomedical Big Data, </institution><institution>Nanjing Medical University, </institution></institution-wrap>Nanjing, 211166 Jiangsu China </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, </institution><institution>University of Copenhagen, </institution></institution-wrap>ØsterFarimagsgade 5, 1353 Copenhagen, Denmark </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Department of Epidemiology, School of Public Health, </institution><institution>Nanjing Medical University, </institution></institution-wrap>Nanjing, 211166 Jiangsu China </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, </institution><institution>Nanjing Medical University, </institution></institution-wrap>Nanjing, 211166 Jiangsu China </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.460176.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1775 8598</institution-id><institution>Department of Critical Care Medicine, </institution><institution>Wuxi People’s Hospital Affiliated to Nanjing Medical University, </institution></institution-wrap>Wuxi, 214023 Jiangsu China </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Department of Medicine, </institution><institution>Massachusetts General Hospital/Harvard Medical School, </institution></institution-wrap>Boston, MA 02115 USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>6</day>
                <month>6</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>6</day>
                <month>6</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>20</volume>
              <elocation-id>203</elocation-id>
              <history>
                <date date-type="received">
                  <day>16</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>10</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Body mass index (BMI) has been found to be associated with a decreased risk of non-small cell lung cancer (NSCLC); however, the effect of BMI trajectories and potential interactions with genetic variants on NSCLC risk remain unknown.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Cox proportional hazards regression model was applied to assess the association between BMI trajectory and NSCLC risk in a cohort of 138,110 participants from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. One-sample Mendelian randomization (MR) analysis was further used to access the causality between BMI trajectories and NSCLC risk. Additionally, polygenic risk score (PRS) and genome-wide interaction analysis (GWIA) were used to evaluate the multiplicative interaction between BMI trajectories and genetic variants in NSCLC risk.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Compared with individuals maintaining a stable normal BMI (<italic>n</italic> = 47,982, 34.74%), BMI trajectories from normal to overweight (<italic>n</italic> = 64,498, 46.70%), from normal to obese (<italic>n</italic> = 21,259, 15.39%), and from overweight to obese (<italic>n</italic> = 4,371, 3.16%) were associated with a decreased risk of NSCLC (hazard ratio [HR] for trend = 0.78, <italic>P</italic> &lt; 2×10<sup>−16</sup>). An MR study using BMI trajectory associated with genetic variants revealed no significant association between BMI trajectories and NSCLC risk. Further analysis of PRS showed that a higher GWAS-identified PRS (PRS<sub>GWAS</sub>) was associated with an increased risk of NSCLC, while the interaction between BMI trajectories and PRS<sub>GWAS</sub> with the NSCLC risk was not significant (<italic>P</italic><sub><italic>s</italic>PRS</sub>= 0.863 and <italic>P</italic><sub><italic>w</italic>PRS</sub>= 0.704). In GWIA analysis, four independent susceptibility loci (<italic>P</italic> &lt; 1×10<sup>−6</sup>) were found to be associated with BMI trajectories on NSCLC risk, including rs79297227 (12q14.1, located in SLC16A7, <italic>P</italic><sub>interaction</sub> = 1.01×10<sup>−7</sup>), rs2336652 (3p22.3, near CLASP2, <italic>P</italic><sub>interaction</sub> = 3.92×10<sup>−7</sup>), rs16018 (19p13.2, in CACNA1A, <italic>P</italic><sub>interaction</sub> = 3.92×10<sup>−7</sup>), and rs4726760 (7q34, near BRAF, <italic>P</italic><sub>interaction</sub> = 9.19×10<sup>−7</sup>). Functional annotation demonstrated that these loci may be involved in the development of NSCLC by regulating cell growth, differentiation, and inflammation.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">Our study has shown an association between BMI trajectories, genetic factors, and NSCLC risk. Interestingly, four novel genetic loci were identified to interact with BMI trajectories on NSCLC risk, providing more support for the aetiology research of NSCLC.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par5"><ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">http://www.clinicaltrials.gov</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01696968">NCT01696968</ext-link>.</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s12916-022-02400-6.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Body mass index</kwd>
                <kwd>Trajectory</kwd>
                <kwd>Genome-wide interaction study</kwd>
                <kwd>Non-small cell lung cancer</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012246</institution-id>
                      <institution>Priority Academic Program Development of Jiangsu Higher Education Institutions</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01CA209414</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Christiani</surname>
                      <given-names>David C.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
                      <institution>National Natural Science Foundation of China</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>82173620</award-id>
                  <award-id>81530088</award-id>
                  <award-id>81820108028</award-id>
                  <award-id>81922061</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Ma</surname>
                      <given-names>Hongxia</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>Hongbing</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Feng</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Yang</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par32">Lung cancer is one of the most common cancers and a leading cause of cancer-related death worldwide [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In 2018, there were 2.09 million new cases and 1.76 million deaths of lung cancer worldwide, accounting for 11.6% and 18.4% of all cancer cases and deaths, respectively [<xref ref-type="bibr" rid="CR3">3</xref>]. In particular, non-small cell lung cancer (NSCLC), the most common type of lung cancer, accounts for approximately 85% of all lung cancer cases [<xref ref-type="bibr" rid="CR4">4</xref>]. Due to the increasing burden of NSCLC, it is necessary to identify more potential risk factors associated with NSCLC so as to develop individualized prevention strategies.</p>
              <p id="Par33">Obesity, usually defined as body mass index (BMI) ≥ 30 kg/m<sup>2</sup>, is becoming an increasingly common global health problem [<xref ref-type="bibr" rid="CR5">5</xref>]. The global prevalence of obesity in adults increased steadily between 1975 and 2016, from 3 to 11% in men and 6 to 15% in women [<xref ref-type="bibr" rid="CR6">6</xref>]. Several epidemiological studies have demonstrated that a higher BMI is associated with a lower risk of NSCLC in European and Asian populations [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], which was also confirmed by a recent meta-analyses with a sample size of 7,310,130 participants [<xref ref-type="bibr" rid="CR8">8</xref>]. However, most of these studies only used BMI at a single time point instead of considering the role of longitudinal BMI trajectories across the life course. In addition, a number of studies have shown that BMI trajectory from normal weight to obesity was associated with the risk of multiple cancers, including prostate, colorectal, oesophageal, gastric cardia adenocarcinoma, and even lung cancer [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>].</p>
              <p id="Par34">Although environmental risk factors (e.g. BMI) are the main risk factors for NSCLC [<xref ref-type="bibr" rid="CR12">12</xref>], genetic susceptibility is also an important contributor [<xref ref-type="bibr" rid="CR13">13</xref>]. The heritability of lung cancer in European and Asian populations is estimated to be 12–21% [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Previous genome-wide association studies (GWAS) identified more than 80 susceptibility variants associated with lung cancer in European and Asian populations, mainly NSCLC, as it is the main type of lung cancer; however, these variants could only explain a small proportion of the overall genetic variance [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Interestingly, there is accumulating evidence that gene-environment interactions may be responsible for the missing heritability of cancer and act together with environmental risk factors in the pathogenesis of cancer [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p>
              <p id="Par35">However, it remained unclear whether there was evidence to support the joint association between BMI trajectories and genetic variants on NSCLC incidence. In this study, we comprehensively investigated the relationship between BMI trajectories and NSCLC risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. In addition, we applied a genome-wide interaction analysis to further assess the effect of different BMI trajectories in participants stratified according to genetic variants on NSCLC risk, which can provide novel insights into the pathophysiology of NSCLC.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study population</title>
                <p id="Par36">The PLCO Cancer Screening Trial is a population-based cohort study aimed to evaluate the accuracy and reliability of screening methods for prostate, lung, colorectal, and ovarian cancer, which randomly recruited 154,897 individuals aged 49–78 years from 10 centres in the USA between 1993 and 2001 [<xref ref-type="bibr" rid="CR20">20</xref>]. Exclusion criteria included (i) personal history of cancer prior to trial entry (<italic>n</italic> = 11,803); (ii) individuals with missing BMI at any age (<italic>n</italic> = 3,504) or BMI &lt; 15 or &gt; 50 kg/m<sup>2</sup> (<italic>n</italic> = 361); (iii) individuals failing to return or complete the baseline questionnaire (<italic>n</italic> = 669); (iv) individuals at enrolment with age &lt; 50 years (<italic>n</italic> = 2); and (v) individuals with small cell lung cancer (<italic>n</italic> = 448). Ultimately, a total of 138,110 participants were retained for analysis. No included individuals had been diagnosed with lung cancer at the time of voluntarily joining the study. The diagnosis of NSCLC was histologically confirmed via medical record reviews, the National Death Index (for completeness), and self-reported annual questionnaires during follow-up [<xref ref-type="bibr" rid="CR21">21</xref>]. This study was approved by the ethics committees of the PLCO consortium providers (PLCO-424). Additional information for the study subjects is presented in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1 [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
              </sec>
              <sec id="Sec4">
                <title>BMI and BMI trajectories ascertainment</title>
                <p id="Par37">Height (m) and body weight (kg) at age 20, 50, and enrolment were collected from self-recorded questionnaires completed by the participants in the PLCO study (<ext-link ext-link-type="uri" xlink:href="https://cdas.cancer.gov/datasets/plco/90/">https://cdas.cancer.gov/datasets/plco/90/</ext-link>). BMI at each age period was calculated using the formula body weight (kg)/height (m<sup>2</sup>). Individuals were classified according to their BMI in each age period according to the World Health Organization 2000 criteria: underweight (&lt;18.5 kg/m<sup>2</sup>), normal weight (18.5–24.9 kg/m<sup>2</sup>), overweight (25.0–29.9 kg/m<sup>2</sup>), and obesity (&gt;30 kg/m<sup>2</sup>) [<xref ref-type="bibr" rid="CR23">23</xref>]. To assess the relationship between pre-diagnostic BMI changes, defined as BMI from the age of 20 or 50 to the entry, and the risk of NSCLC at age 20, 50, and entry, latent class growth model (LCGM) was used to identify longitudinal patterns of BMI change at three-time points during adulthood [<xref ref-type="bibr" rid="CR24">24</xref>]. Specifically, the LCGM here was fitted using linear and quadratic polynomials with three to five trajectory categories (individuals per trajectory ≥ 1%), and the model with the highest number of fitting categories was selected using the Bayesian Information Criterion (BIC) method and the average posterior probability (AvePP) of each trajectory [<xref ref-type="bibr" rid="CR25">25</xref>]. Detailed information for the calculation of BMI trajectories is provided in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1 [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p>
              </sec>
              <sec id="Sec5">
                <title>Genotyping</title>
                <p id="Par38">The PLCO GWAS data were deposited in the database of Genotypes and Phenotypes (dbGaP, phs001286.v1.p1 and phs000336.v1.p1), including a total of 14,497 participants genotyped using Illumina Hap240, Hap300, and Hap550 [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. The use of the PLCO genetic datasets was approved by both the Internal Review Board of Nanjing Medical University and the dbGaP database administration (#21708 and #21643). Basic information on genotyping and imputation for PLCO GWAS data is shown in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1 [<xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. Additional quality control procedures for individuals and single nucleotide polymorphisms (SNPs) levels are presented in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1. Ultimately, 13,365 individuals remained in the genetic analysis (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).</p>
              </sec>
              <sec id="Sec6">
                <title>Analysis of the interaction between the GWAS-based polygenic risk score (PRS) and BMI trajectories</title>
                <p id="Par39">Based on 81 previously reported GWAS SNPs associated with lung cancer in European and Asian populations [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], and a strict quality control process, including (i) SNPs located within autosomal chromosomes; (ii) minor allele frequency (MAF) ≥ 0.05; (iii) call rate ≥ 95%; (iv) <italic>P</italic>-value for Hardy-Weinberg Equilibrium (HWE) among non-NSCLC individuals ≥ 1.0×10<sup>−6</sup>; (v) imputation INFO &gt; 0.3; and (vi) a risk effect consistent with previous results, we identified 19 independent [linkage disequilibrium (LD), <italic>r</italic><sup><italic>2</italic></sup> &lt; 0.5] GWAS-identified SNPs (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2) to construct the simple-count PRS (<italic>s</italic>PRS) and weighted PRS (<italic>w</italic>PRS) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. The <italic>s</italic>PRS is equal to the number of risk alleles, which can be estimated as <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$sPRS=\sum \limits_{i=1}^I{G}_i$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mi>s</mml:mi><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>I</mml:mi></mml:munderover><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12916_2022_2400_Article_IEq1.gif"/></alternatives></inline-formula>, where G<sub><italic>i</italic></sub> (i.e. 0, 1, or 2) denotes the number of risk alleles of <italic>i</italic>th SNP. The <italic>w</italic>PRS was calculated using the formula: <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$wPRS=\sum \limits_{i=1}^I{\beta}_i{G}_i$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi>w</mml:mi><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>I</mml:mi></mml:munderover><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12916_2022_2400_Article_IEq2.gif"/></alternatives></inline-formula>, where <italic>β</italic><sub><italic>i</italic></sub> is the per allele ORs derived from previous studies [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Additional information on the analysis of the interaction between the PRS<sub>GWAS</sub> and BMI trajectory is presented in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1.</p>
              </sec>
              <sec id="Sec7">
                <title>Genome-wide interaction analysis (GWIA)</title>
                <p id="Par40">GWIA was performed to test for the gene-environment interactions between genome-wide SNPs and BMI trajectories. The interaction was modelled by determining the multiplicative product of SNP genotype and BMI trajectories in the Cox proportional hazard regression model, adjusting for age, sex, race, family history of lung cancer, education, smoking status, personal history of diabetes, current marital status, study centre, and the first 10 principal components. For GWIA, the <italic>P</italic>-value of the interaction term &lt; 1.0×10<sup>−6</sup> was considered statistically significant [<xref ref-type="bibr" rid="CR34">34</xref>]. Similar to the construction of PRS<sub>GWAS</sub>, the GWIA-based <italic>s</italic>PRS (<italic>s</italic>PRS<sub>GWIA</sub>) or <italic>w</italic>PRS (<italic>w</italic>PRS<sub>GWIA</sub>) was also calculated to evaluate the cumulative interaction effects with BMI trajectories, separately.</p>
              </sec>
              <sec id="Sec8">
                <title>Functional annotation</title>
                <p id="Par41">Functional annotation was conducted to explore the potential molecular roles of the GWIA-identified loci by (i) pinpointing the most likely candidate genes at the identified loci by identifying <italic>cis</italic>-expression quantitative trait loci (<italic>cis</italic>-eQTL) within no more than 1 Mb of each investigated SNP in the Genotype-Tissue Expression project (version 7.0, <ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org/home/">http://www.gtexportal.org/home/</ext-link>) database from multiple relevant tissues [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>] and (ii) using the Encyclopedia of DNA Elements [<xref ref-type="bibr" rid="CR37">37</xref>], HaploReg (version 4.1) [<xref ref-type="bibr" rid="CR38">38</xref>], and RegulomeDB (<ext-link ext-link-type="uri" xlink:href="http://www.regulomedb.org/">http://www.regulomedb.org/</ext-link>) to further assess the regulatory potential for variants of interest.</p>
              </sec>
              <sec id="Sec9">
                <title>Statistical analysis</title>
                <p id="Par42">Cox proportional hazards regression model was used to estimate the hazard ratio (HR) and 95% confidence intervals (CIs) between BMI trajectories and NSCLC risk with adjustments for age, sex, race, family history of lung cancer, education, smoking status, personal history of diabetes, current marital status, and study centre. The proportional hazard assumption was assessed by Schoenfeld residuals [<xref ref-type="bibr" rid="CR39">39</xref>]. Further, continuous variables were adapted to conduct tests of linear trends. Individual follow-up time was defined as a period from entry until the time of NSCLC occurrence (diagnosis) or censoring defined as the exit of the study due to other causes or death, loss to follow-up, or the end of the study.</p>
                <p id="Par43">Interaction effects of PRS<sub>GWAS</sub>, PRS<sub>GWIA</sub>, or each GWIA-identified SNP with BMI trajectories were further investigated by adding multiplicative interaction terms in the Cox models with adjustment for the first 10 principal components. A cumulative incidence function was estimated using Kaplan-Meier technique to quantify the risk of developing NSCLC over time, stratified by GWIA-identified SNPs, and differences in the full time-to-event distributions between different BMI trajectory groups were compared by a log-rank test [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
                <p id="Par44">Subgroup analysis was performed to evaluate the heterogeneity of the association between BMI trajectories and NSCLC risk stratified by sex, smoking status, or histological type. Further, several sensitivity analyses were performed to assess the reliability of the primary results. One-sample Mendelian randomization (MR) analysis was also performed to access the causality between BMI trajectories and NSCLC risk, including inverse-variance-weighted (IVW), Mendelian randomization Egger (MR-Egger), and simple median method. <italic>P</italic> values (two-sided) &lt; 0.05 were deemed significant. All analyses were performed using R 3.5.3 and PLINK 1.90 software. Additional information is presented in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1.</p>
              </sec>
            </sec>
            <sec id="Sec10">
              <title>Results</title>
              <p id="Par45">There were 138,110 individuals in the prospective cohort study (Table <xref rid="Tab1" ref-type="table">1</xref>). In total, 2641 NSCLC patients with a mean age of 64.34 years (SD = 5.20) were confirmed, including 2343 (88.72%) whites and 298 (11.28%) non-whites (184 blacks, 32 Hispanics, 63 Asians, and 19 others) populations. Compared with non-NSCLC individuals, NSCLC was more common among participants who were male (HR = 0.61, 95% CI: 0.56 to 0.66, <italic>P</italic> &lt; 2×10<sup>−16</sup>), older (HR = 1.06, 95% CI: 1.05 to 1.07, <italic>P</italic> &lt; 2×10<sup>−16</sup>), non-Hispanic Blacks (HR = 1.58, 95% CI: 1.36 to 1.84, <italic>P</italic> = 2.32×10<sup>−9</sup>), and current (HR = 24.22, 95% CI: 20.93 to 28.03, <italic>P</italic> &lt; 2×10<sup>−16</sup>) or ever smoker (HR = 6.94, 95% CI: 6.01 to 8.01, <italic>P</italic> &lt; 2×10<sup>−16</sup>); had a family history of lung cancer (HR = 1.83, 95% CI: 1.66 to 2.03, <italic>P</italic> &lt; 2×10<sup>−16</sup>); had a low level of education (HR = 0.63, 95% CI: 0.58 to 0.69, <italic>P</italic> &lt; 2×10<sup>−16</sup>); had a history of diabetes (HR = 1.25, 95% CI: 1.09 to 1.44, <italic>P</italic> = 0.001); and were divorced, separated, or widowed (HR = 1.41, 95% CI: 1.30 to 1.54, <italic>P</italic> = 1.08×10<sup>−14</sup>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the study subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>Total (<italic>N</italic>=138,110)</th><th>NSCLC (<italic>N</italic>=2641)</th><th>Non-NSCLC (<italic>N</italic>=135,469)</th><th>HR (95% CI)</th><th><italic>P</italic>-value*</th></tr></thead><tbody><tr><td>Age (years)<sup>a</sup>, Mean ± SD</td><td>62.56 ± 5.34</td><td>64.34 ± 5.20</td><td>62.53 ± 5.34</td><td>1.06 (1.05, 1.07)</td><td>&lt; 2×10<sup>−16</sup></td></tr><tr><td colspan="6">Sex, <italic>N</italic> (%)</td></tr><tr><td> Male</td><td>69,713 (50.48)</td><td>1646 (62.32)</td><td>68,067 (50.25)</td><td>Reference</td><td/></tr><tr><td> Female</td><td>68,397 (49.52)</td><td>995 (37.68)</td><td>67,402 (49.75)</td><td>0.61 (0.56, 0.66)</td><td>&lt; 2×10<sup>−16</sup></td></tr><tr><td colspan="6">Race, <italic>N</italic> (%)</td></tr><tr><td> White, non-Hispanic</td><td>122,404 (88.63)</td><td>2343 (88.72)</td><td>120,061 (88.63)</td><td>Reference</td><td/></tr><tr><td> Black, non-Hispanic</td><td>6868 (4.97)</td><td>184 (6.97)</td><td>6684 (4.93)</td><td>1.58 (1.36, 1.84)</td><td>2.32×10<sup>−9</sup></td></tr><tr><td> Hispanic</td><td>2552 (1.85)</td><td>32 (1.20)</td><td>2520 (1.86)</td><td>0.70 (0.50, 1.00)</td><td>0.049</td></tr><tr><td> Asian</td><td>5133 (3.72)</td><td>63 (2.39)</td><td>5070 (3.74)</td><td>0.62 (0.48, 0.80)</td><td>2.09×10<sup>−4</sup></td></tr><tr><td> Other</td><td>1153 (0.83)</td><td>19 (0.72)</td><td>1134 (0.84)</td><td>0.91 (0.58, 1.43)</td><td>0.673</td></tr><tr><td colspan="6">Family history of lung cancer, <italic>N</italic> (%)</td></tr><tr><td> Absent</td><td>119,147 (86.88)</td><td>2050 (78.21)</td><td>117,097 (87.05)</td><td>Reference</td><td/></tr><tr><td> Present</td><td>14,376 (10.48)</td><td>447 (17.05)</td><td>13,929 (10.35)</td><td>1.83 (1.66, 2.03)</td><td>&lt; 2×10<sup>−16</sup></td></tr><tr><td> Missing</td><td>3616 (2.64)</td><td>124 (4.73)</td><td>4443 (2.60)</td><td/><td/></tr><tr><td colspan="6">Education, <italic>N</italic> (%)</td></tr><tr><td> HS or less</td><td>41,506 (30.05)</td><td>1007 (38.13)</td><td>40,499 (29.90)</td><td>Reference</td><td/></tr><tr><td> Post HS or some college</td><td>47,376 (34.30)</td><td>986 (37.33)</td><td>46,390 (34.24)</td><td>0.90 (0.80, 1.01)</td><td>0.065</td></tr><tr><td> College graduate or degree</td><td>48,968 (35.46)</td><td>645 (24.42)</td><td>48,323 (35.67)</td><td>0.63 (0.58, 0.69)</td><td>&lt; 2×10<sup>−16</sup></td></tr><tr><td> Missing</td><td>260 (0.19)</td><td>3 (0.12)</td><td>257 (0.19)</td><td/><td/></tr><tr><td>BMI at age 20 (kg/m<sup>2</sup>), Mean ± SD</td><td>22.10 ± 3.01</td><td>22.11 ± 2.99</td><td>22.10 ± 3.01</td><td>1.00 (0.99, 1.02)</td><td>0.520</td></tr><tr><td>BMI at age 50 (kg/m<sup>2</sup>), Mean ± SD</td><td>25.85 ± 4.17</td><td>25.16 ± 3.70</td><td>25.87 ± 4.18</td><td>0.96 (0.95, 0.97)</td><td>5.66×10<sup>−15</sup></td></tr><tr><td>BMI at baseline (kg/m<sup>2</sup>), Mean ± SD</td><td>27.30 ± 4.75</td><td>26.49 ± 4.43</td><td>27.32 ± 4.75</td><td>0.96 (0.95, 0.97)</td><td>3.65×10<sup>−16</sup></td></tr><tr><td colspan="6">Smoking status, <italic>N</italic> (%)</td></tr><tr><td> Never</td><td>63,945 (46.30)</td><td>217 (8.22)</td><td>63,728 (47.04)</td><td>Reference</td><td/></tr><tr><td> Former</td><td>59,685 (43.22)</td><td>1365 (51.68)</td><td>58,320 (43.06)</td><td>6.94 (6.01, 8.01)</td><td>&lt; 2×10<sup>−16</sup></td></tr><tr><td> Current</td><td>14,464 (10.47)</td><td>1059 (40.10)</td><td>13,405 (9.89)</td><td>24.22 (20.93, 28.03)</td><td>&lt; 2×10<sup>−16</sup></td></tr><tr><td> Missing</td><td>16 (0.01)</td><td>0</td><td>16 (0.01)</td><td/><td/></tr><tr><td colspan="6">Personal history of diabetes, <italic>N</italic> (%)</td></tr><tr><td> Absent</td><td>127,024 (91.97)</td><td>2398 (90.80)</td><td>124,626 (92.00)</td><td>Reference</td><td/></tr><tr><td> Present</td><td>10,426 (7.55)</td><td>221 (8.37)</td><td>10,205 (7.53)</td><td>1.25 (1.09, 1.44)</td><td>0.001</td></tr><tr><td> Missing</td><td>660 (0.48)</td><td>22 (0.83)</td><td>638 (0.47)</td><td/><td/></tr><tr><td colspan="6">Current marital status, <italic>N</italic> (%)</td></tr><tr><td> Married or living with someone</td><td>105,276 (76.23)</td><td>1890 (70.96)</td><td>103,386 (76.32)</td><td>Reference</td><td/></tr><tr><td> Divorced, separated, or widowed</td><td>28,030 (20.30)</td><td>677 (26.35)</td><td>27,353 (20.19)</td><td>1.41 (1.30, 1.54)</td><td>1.08×10<sup>−14</sup></td></tr><tr><td> Single, never married</td><td>4580 (3.32)</td><td>71 (2.56)</td><td>4509 (3.33)</td><td>0.91 (0.71, 1.15)</td><td>0.409</td></tr><tr><td> Missing</td><td>224 (0.15)</td><td>3 (0.13)</td><td>221 (0.16)</td><td/><td/></tr><tr><td colspan="6">Hormone replacement therapy (in female), <italic>N</italic> (%)</td></tr><tr><td> Never</td><td>22,083 (32.31)</td><td>389 (39.10)</td><td>21,694 (32.19)</td><td>Reference</td><td/></tr><tr><td> Current</td><td>34,779 (50.82)</td><td>411 (41.31)</td><td>34,368 (50.99)</td><td>0.67 (0.58, 0.77)</td><td>1.09×10<sup>−8</sup></td></tr><tr><td> Former</td><td>11,120 (16.26)</td><td>187 (18.79)</td><td>10,933 (16.22)</td><td>0.95 (0.80, 1.14)</td><td>0.600</td></tr><tr><td> Missing</td><td>353 (0.61)</td><td>8 (0.80)</td><td>345 (0.60)</td><td/><td/></tr><tr><td colspan="6">Study centre, <italic>N</italic> (%)</td></tr><tr><td> 1 = University of Colorado</td><td>11,852 (8.58)</td><td>178 (6.74)</td><td>11,674 (8.62)</td><td>Reference</td><td/></tr><tr><td> 2 = Georgetown University</td><td>6294 (4.56)</td><td>111 (4.20)</td><td>6183 (4.56)</td><td>1.13 (0.89, 1.43)</td><td>0.310</td></tr><tr><td> 3 = Pacific Health Research and Education Institute (Honolulu)</td><td>9362 (6.78)</td><td>176 (6.66)</td><td>9186 (6.78)</td><td>1.24 (1.01, 1.53)</td><td>0.045</td></tr><tr><td> 4 = Henry Ford Health System</td><td>21,887 (15.85)</td><td>442 (16.74)</td><td>21,445 (15.83)</td><td>1.47 (1.24, 1.75)</td><td>1.35×10<sup>−5</sup></td></tr><tr><td> 5 = University of Minnesota</td><td>24,613 (17.82)</td><td>510 (19.31)</td><td>24,103 (17.79)</td><td>1.36 (1.15, 1.62)</td><td>3.83×10<sup>−4</sup></td></tr><tr><td> 6 = Washington University in St Louis</td><td>13,763 (9.96)</td><td>310 (11.74)</td><td>13,453 (9.93)</td><td>1.54 (1.28, 1.85)</td><td>4.60×10<sup>−6</sup></td></tr><tr><td> 8 = University of Pittsburgh</td><td>16,021 (11.60)</td><td>350 (13.25)</td><td>15,671 (11.57)</td><td>1.48 (1.23, 1.77)</td><td>2.31×10<sup>−5</sup></td></tr><tr><td> 9 = University of Utah</td><td>13,449 (9.74)</td><td>175 (6.63)</td><td>13,274 (9.80)</td><td>0.87 (0.70, 1.07)</td><td>0.180</td></tr><tr><td> 10 = Marshfield Clinic Research Foundation</td><td>15,153 (10.97)</td><td>289 (10.94)</td><td>14,864 (10.97)</td><td>1.25 (1.04, 1.51)</td><td>0.017</td></tr><tr><td> 11 = University of Alabama at Birmingham</td><td>5716 (4.14)</td><td>100 (3.79)</td><td>5616 (4.15)</td><td>1.44 (1.13, 1.84)</td><td>0.004</td></tr></tbody></table><table-wrap-foot><p>*Univariate cox proportional hazard regression model</p><p><sup>a</sup>Age at the time of study enrolment</p><p><italic>NSCLC</italic> non-small cell lung cancer, <italic>BMI</italic> body mass index, <italic>HR</italic> hazard ratio, <italic>CI</italic> confidence interval</p></table-wrap-foot></table-wrap></p>
              <p id="Par46">No evidence of departure from the proportional hazard assumption in Cox models for NSCLC (<italic>P</italic> = 0.166) was found. Cox proportional hazards model showed that a higher BMI at 20 years, 50 years, and the time of enrolment (baseline) were associated with a decreased risk of NSCLC (HR = 0.88, <italic>P</italic> = 0.001; HR = 0.70, <italic>P</italic> &lt; 2×10<sup>−16</sup>; HR = 0.75, <italic>P</italic> &lt; 2×10<sup>−16</sup>, respectively), and similar findings were observed in categorical BMI (decreased risk in overweight and obesity, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3). Further, we identified four distinct BMI trajectories by the latent class growth model (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Compared with participants with a stable normal BMI in their adulthood (<italic>n</italic> = 47,982, 34.74%), the risk of NSCLC decreased in participants who progressed from a normal BMI to an overweight BMI at baseline (<italic>n</italic> = 64,498, 46.70%, HR = 0.77, 95% CI: 0.70 to 0.84, <italic>P</italic> = 3.80×10<sup>−9</sup>), who progressed from a normal BMI to an obese BMI at baseline (<italic>n</italic> = 21,259, 15.39%, HR = 0.60, 95% CI: 0.53 to 0.69, <italic>P</italic> = 5.42×10<sup>−13</sup>), and who were overweight at the onset of adulthood and became obese at baseline (<italic>n</italic> = 4371, 3.16%, HR = 0.54, 95% CI: 0.40 to 0.74, <italic>P</italic> = 9.33×10<sup>−5</sup>). Interestingly, the NSCLC risk decreased gradually across all three BMI trajectories (HR for trend = 0.78, 95%CI: 0.74 to 0.83, <italic>P</italic> = 2×10<sup>−16</sup>) compared with subjects who maintained a normal BMI. Sensitivity analyses showed that the primary model retained a stable association between BMI trajectories and NSCLC risk (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S4). Furthermore, stratified analyses by sex, smoking status, and histological type showed almost no significant heterogeneity in the effect of age-specific BMI and BMI trajectories on NSCLC risk, although the <italic>P</italic> value for the heterogeneity test was less than 0.05 among those with BMI &lt; 18.5 at baseline stratified by sex (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S1-S3).<fig id="Fig1"><label>Fig. 1</label><caption><p>The latent class growth model of BMI trajectories in the PLCO study. <bold>A</bold> BMI changes for each participant in each trajectory group across three analysed age points (ages of 20 years, 50 years, and baseline). <bold>B</bold> Each trajectory was calculated at any of the three analysed age points (ages of 20 years, 50 years, and baseline). HR and 95% CI were estimated by Cox proportional hazards regression model with the adjustment for age, sex, race, family history of lung cancer, education, smoking, personal history of diabetes, current marital status, and study centre</p></caption><graphic xlink:href="12916_2022_2400_Fig1_HTML" id="MO1"/></fig></p>
              <p id="Par47">Nineteen GWAS-identified SNPs were used to construct the PRS and examine the potential effect of BMI trajectories on NSCLC risk according to the genetic variants. The characteristics of 13,365 individuals from the GWAS are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Appendix S1. Nineteen GWAS-identified SNPs associated with lung cancer were used to construct the <italic>s</italic>PRS and <italic>w</italic>PRS (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2). Furthermore, compared with the low tertiles of <italic>s</italic>PRS<sub>GWAS</sub>, the middle and high tertiles of <italic>s</italic>PRS<sub>GWAS</sub> were associated with a higher probability of NSCLC (HR = 1.13, 95% CI: 1.12 to 1.59, <italic>P</italic> = 0.001; HR = 1.56, 95% CI: 1.34 to 1.82, <italic>P</italic> = 1.62×10<sup>−8</sup>, respectively) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S5). Similar results were obtained for <italic>w</italic>PRS<sub>GWAS</sub>, indicating that a higher PRS<sub>GWAS</sub> was associated with an increased risk of NSCLC. However, there was no significant interaction between BMI trajectories and PRS<sub>GWAS</sub> with the NSCLC risk (<italic>P</italic><sub><italic>s</italic>PRS</sub>= 0.863 and <italic>P</italic><sub><italic>w</italic>PRS</sub>= 0.704; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4). Similar findings were observed for age-specific BMI (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S6-S7).</p>
              <p id="Par48">GWIA was subsequently performed to investigate the effect of the genome-wide interaction between each SNP and BMI trajectories on the NSCLC risk. A Manhattan plot was constructed to show the significant SNPs that interacted with BMI trajectories (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5). Four independent SNPs reached statistically suggestive significance [<xref ref-type="bibr" rid="CR34">34</xref>] instead of genome-wide significance in GWIA, which were also confirmed in the bootstrap and permutation tests (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S8). Among the four SNPs, rs79297227 with the lowest <italic>P</italic> value (1.01×10<sup>−7</sup>) located in SLC16A7 (12q14.1) showed a statistically suggestively significant interaction with the BMI trajectories, and the remaining three SNPs, including rs2336652 near <italic>CLASP2</italic> (3p22.3, <italic>P</italic> = 3.92×10<sup>−7</sup>), rs16018 in <italic>CACNA1A</italic> (19p13.2, <italic>P</italic> = 3.92×10<sup>−7</sup>), and rs4726760 near <italic>BRAF</italic> (7q34, <italic>P</italic> = 9.19×10<sup>−7</sup>) interacted with the BMI trajectories in terms of the NSCLC risk. Similar results were obtained from the analysis stratified by genotype (Table <xref rid="Tab2" ref-type="table">2</xref>). Figure <xref rid="Fig2" ref-type="fig">2</xref>B displays the cumulative incidence of NSCLC stratified by GWIA-identified SNPs by the log-rank test. In the sensitivity analysis, a significant interaction was observed between four SNPs and the BMI trajectories by additionally adjusting for occupation and family history of any cancer or performing other sensitivity analyses (almost <italic>P</italic> &lt; 1.0×10<sup>−4</sup>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S9). MR sensitivity analyses showed that the correlation direction between BMI trajectories and NSCLC risk was consistent with the above analysis, although no meaningful differences in these results were observed, with no evidence of directional pleiotropy (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S10-S11). For the functional annotation, the search for cis-eQTLs at the four loci detected by GWIA showed that SNP rs4726760 at 7q34 was a strong cis-eQTL for <italic>BRAF</italic> (<italic>P</italic> = 0.011, <italic>β</italic> = 0.073) in the lung tissue. No cis-eQTL was found at the other three loci (rs16018, <italic>P</italic> = 0.070, <italic>β</italic> = 0.128; rs2336652, <italic>P</italic> = 0.854, <italic>β</italic> = −0.015; rs79297227, <italic>P</italic> = 0.376, <italic>β</italic> = −0.042) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6A). SNP rs16018 is located on chromosome 19p13.2 in <italic>calcium voltage-gated channel subunit alpha1 A</italic> (<italic>CACNA1A)</italic>, which is a protein-coding gene involved in calcium channel regulation; SNP rs2336652 at 3p22.3 is located near <italic>cytoplasmic linker-associated protein 2</italic> (<italic>CLASP2)</italic>,which is significantly expressed in lung tissue and promotes the stability of microtubules; and SNP rs79297227 at 12q14.1 is located in the <italic>solute carrier family 16 member 7</italic> (<italic>SLC16A7</italic>), which is not only significantly expressed in lung tissues (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6B) but also expressed in various types of malignant tumours.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Association between BMI trajectories and NSCLC risk stratified by the four susceptibility SNPs</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">SNP/Genotype</th><th colspan="4">BMI trajectory</th><th rowspan="2">HR<sub><italic>trend</italic></sub> (95% CI)</th><th rowspan="2"><italic>P</italic><sub><italic>trend</italic></sub></th><th rowspan="2"><italic>P</italic><sub><italic>interaction</italic></sub></th></tr><tr><th>Normal BMI</th><th>Normal to overweight</th><th>Normal to obese</th><th>Overweight to obese</th></tr></thead><tbody><tr><td>rs79297227</td><td/><td/><td/><td/><td/><td/><td>1.01×10<sup>−7</sup></td></tr><tr><td> TT</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>402/2947</td><td>481/5593</td><td>111/1772</td><td>14/268</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.75 (0.65, 0.85)</td><td>0.53 (0.42, 0.67)</td><td>0.42 (0.24, 0.74)</td><td>0.74 (0.67, 0.81)</td><td>3.37×10<sup>−10</sup></td><td/></tr><tr><td> TC/CC</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>30/353</td><td>39/583</td><td>34/199</td><td>4/29</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>1.06 (0.62, 1.81)</td><td>2.54 (1.42, 4.53)</td><td>1.73 (0.49, 6.05)</td><td>1.49 (1.14, 1.94)</td><td>0.003</td><td/></tr><tr><td>rs2336652</td><td/><td/><td/><td/><td/><td/><td>3.92×10<sup>−7</sup></td></tr><tr><td> CC</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>408/3031</td><td>465/5692</td><td>115/1810</td><td>13/282</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.72 (0.63, 0.84)</td><td>0.54 (0.43, 0.68)</td><td>0.34 (0.18, 0.62)</td><td>0.73 (0.66, 0.80)</td><td>6.51×10<sup>−11</sup></td><td/></tr><tr><td> CA/AA</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>40/398</td><td>64/734</td><td>32/229</td><td>4/31</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.98 (0.64, 1.51)</td><td>1.85 (1.09, 3.12)</td><td>2.05 (0.69, 6.10)</td><td>1.33 (1.04, 1.70)</td><td>0.025</td><td/></tr><tr><td>rs16018</td><td/><td/><td/><td/><td/><td/><td>3.92×10<sup>−7</sup></td></tr><tr><td> AA</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>252/1645</td><td>233/3103</td><td>63/983</td><td>4/153</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.58 (0.48, 0.70)</td><td>0.49 (0.36, 0.66)</td><td>0.12 (0.03, 0.47)</td><td>0.64 (0.56, 0.73)</td><td>8.56×10<sup>−11</sup></td><td/></tr><tr><td> AG/GG</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>197/1789</td><td>299/3328</td><td>84/1058</td><td>14/160</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.94 (0.78, 1.14)</td><td>0.81 (0.62, 1.08)</td><td>0.87 (0.50, 1.52)</td><td>0.92 (0.82, 1.04)</td><td>0.187</td><td/></tr><tr><td>rs4726760</td><td/><td/><td/><td/><td/><td/><td>9.19×10<sup>−7</sup></td></tr><tr><td> CC</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>308/2528</td><td>412/4656</td><td>121/1433</td><td>16/235</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.88 (0.76, 1.04)</td><td>0.86 (0.69, 1.09)</td><td>0.57 (0.33, 0.98)</td><td>0.90 (0.81, 0.99)</td><td>0.030</td><td/></tr><tr><td> CT/TT</td><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>  NSCLC/Non-NSCLC</td><td>126/811</td><td>110/1589</td><td>23/522</td><td>1/68</td><td/><td/><td/></tr><tr><td>  HR (95% CI)<sup>a</sup></td><td>Reference</td><td>0.47 (0.35, 0.62)</td><td>0.24 (0.14, 0.40)</td><td>0.13 (0.02, 0.95)</td><td>0.48 (0.39, 0.59)</td><td>2.07×10<sup>−11</sup></td><td/></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Cox proportional hazard regression model adjusted age, sex, race, family history of lung cancer, education, smoking, personal history of diabetes, current marital status, study centre, and first10 principal component</p><p><italic>BMI</italic> body mass index, <italic>NSCLC</italic> non-small cell lung cancer, <italic>SNPs</italic> single nucleotide polymorphisms, <italic>HR</italic> hazard ratio, <italic>CI</italic> confidence interval</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Stratifications analysis for the interaction effects between BMI trajectories and GWIA-identified SNPs on NSCLC risk. <bold>A</bold> The identified four BMI trajectories from the onset of adulthood to the baseline. <bold>B</bold> Cumulative incidence of NSCLC stratified by GWIA-identified SNPs. <italic>P</italic>-value was derived from the Log-rank test. <bold>C</bold> Pathway of the gene (BRAF)-BMI trajectories interaction effect on the risk of NSCLC</p></caption><graphic xlink:href="12916_2022_2400_Fig2_HTML" id="MO2"/></fig></p>
              <p id="Par49">GWIA-based PRS of the four SNPs above was constructed to evaluate the cumulative interaction with BMI trajectories on NSCLC risk (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). Although a significant association was identified between BMI trajectories and a higher NSCLC risk among the individuals with high tertiles of <italic>w</italic>PRS<sub>GWIA</sub> (HR for trend =1.30, 95% CI = 1.10–1.54), interestingly, BMI trajectories were also associated with a decreased risk of NSCLC among individuals with a low (0.54, 0.47–0.62) or intermediate tertiles of <italic>w</italic>PRS<sub>GWIA</sub> (0.85, 0.72–0.99), indicating an obvious interaction between the GWIA-based <italic>w</italic>PRS<sub>GWIA</sub> and BMI trajectories. Similar findings were observed for age-specific BMI (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S12). The interaction between BMI trajectories and PRS<sub>GWIA</sub> with the NSCLC risk was significant (<italic>P</italic><sub><italic>s</italic>PRS</sub> = 6.61×10<sup>−5</sup> and <italic>P</italic><sub><italic>w</italic>PRS</sub> = 3.80×10<sup>−16</sup>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4). In addition, individuals with low or intermediate tertiles of <italic>w</italic>PRS<sub>GWIA</sub> experienced a gradually decreased cancer risk across the BMI trajectories from normal to normal, normal to overweight, overweight to obese, and normal to obese, while the high tertiles of <italic>w</italic>PRS<sub>GWIA</sub> were just the opposite after adjustment for age, sex, race, family history of lung cancer, education, smoking, personal history of diabetes, current marital status, study centre, and first 10 principal components (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A, B). Stratification analyses for <italic>w</italic>PRS<sub>GWIA</sub> showed that associations between BMI trajectories and NSCLC risk were heterogeneous (<italic>I</italic><sup><italic>2</italic></sup> = 73.09%, <italic>P</italic> for heterogeneity &lt; 0.001, Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). Similar results were also observed in <italic>s</italic>PRS<sub>GWIA</sub> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4CD, Table S13).<fig id="Fig3"><label>Fig. 3</label><caption><p>Interaction analysis and stratification analysis of BMI trajectories and the PRS constructed by four GWIA-identified SNPs on NSCLC risk. <bold>A</bold>, <bold>B</bold><italic>w</italic>PRS<sub>GWIA</sub> were weighted according to the strength of their association with lung cancer. <bold>C</bold>, <bold>D</bold><italic>s</italic>PRS<sub>GWIA</sub> were calculated by simple counting. <italic>P</italic> value for interaction was derived from multivariate-adjusted Cox proportional hazards regression model. PRS, polygenic risk score; GWIA, genome wide interaction analysis; SNP, single nucleotide polymorphism; HR, hazard ratio; CI, confidence interval</p></caption><graphic xlink:href="12916_2022_2400_Fig3_HTML" id="MO3"/></fig></p>
            </sec>
            <sec id="Sec11">
              <title>Discussion</title>
              <p id="Par50">In this multi-centre study, four distinct trajectories of BMI were identified during adulthood, finding that subjects who progressed from a normal BMI at the onset of adulthood to overweight or obesity at baseline (compared to maintaining a stable BMI) had a lower risk of developing NSCLC in this PLCO cohort (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). In addition, interaction analysis provided evidence that the association between BMI trajectories and NSCLC risk slightly differed according to genetic variation at SNPs rs4726760, rs16018, rs2336652, and rs79297227.</p>
              <p id="Par51">The results of this study suggested that the BMI trajectory from normal weight to overweight or obesity was associated with protective effects against NSCLC development, which was consistent with previous epidemiology studies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref>]. Several hypotheses have been postulated to explain the relationship between leanness and a higher risk of lung cancer. For example, smoking, as a dominant risk factor for lung cancer, usually leads to lower body weight, which may explain the observed inverse BMI-lung cancer association. However, several large prospective studies show a negative association between BMI and lung cancer risk, and this association persists after excluding up to 10 years of follow-up, suggesting that it is not entirely due to smoking [<xref ref-type="bibr" rid="CR44">44</xref>]. Moreover, never-smokers were more likely to have a stable normal BMI trajectory according to a stratified analysis of smoking status, although never-smokers in each BMI trajectory group accounted for about 50% of our analysis. Likewise, it has been suggested that weight loss represents a preclinical event prior to the clinical manifestation of lung cancer [<xref ref-type="bibr" rid="CR45">45</xref>]. However, our sensitivity analysis suggested that BMI trajectories resulting in overweight or obesity were associated with a lower risk of lung cancer, even excluding patients who developed the disease during the first, second, or fourth year of follow-up. Interestingly, interaction analysis of PRS<sub>GWIA</sub> with BMI trajectories on NSCLC risk indicated that BMI progressed from normal to overweight or obesity was associated with higher NSCLC risk among individuals with the high tertiles of <italic>w</italic>PRS<sub>GWIA</sub> or <italic>s</italic>PRS<sub>GWIA</sub>. Specifically, they experienced a gradually increased NSCLC risk across the BMI trajectories from normal to normal, normal to overweight, overweight to obese, and normal to obese, although the low or intermediate tertiles of <italic>w</italic>PRS<sub>GWIA</sub> or <italic>s</italic>PRS<sub>GWIA</sub> were just the opposite (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). In addition, those identified SNPs were located in or near genes that might be involved in biological pathways leading to lung cancer. The gene <italic>BRAF</italic> near rs4726760 provides instructions for making a protein that helps transmit chemical signals from outside the cell to the nucleus. This protein is a component of the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway, which regulates several important cell functions including cellular proliferation, differentiation, migration, and apoptosis. Chemical signalling through this pathway is essential for normal development before birth. <italic>BRAF</italic> also is an oncogene. When mutated, oncogenes have the potential to cause normal cells to become cancerous [<xref ref-type="bibr" rid="CR46">46</xref>]. <italic>BRAF</italic> mutations are seen in 3–5% of NSCLC cases [<xref ref-type="bibr" rid="CR47">47</xref>]. It is generally believed that obese people eat nutrient-rich foods, and studies have found that nutrients (antioxidants) can significantly inhibit the MAPK signalling pathway to reduce the inflammation response related to the risk of cancer [<xref ref-type="bibr" rid="CR48">48</xref>]. The MAPK pathway plays an important role in the differentiation of adipocytes [<xref ref-type="bibr" rid="CR49">49</xref>], and ERK is essential for the transcription of gene CCATT/enhancer binding protein α/β/δ and peroxisome proliferator-activated receptor gamma (PPARγ), key factors of adipocyte differentiation. When the ERK signalling pathway is activated, PPARγ is phosphorylated and transcriptional activity is reduced, which inhibits adipocyte differentiation [<xref ref-type="bibr" rid="CR50">50</xref>]. Decreased adipocyte differentiation reduces the accumulation of adipocytes, thereby reducing the incidence of inflammation that may be related to pathological obesity (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C).</p>
              <p id="Par52">The SNP rs16018, a member of the family of voltage-gated calcium channels, is located in the gene <italic>CACNA1A</italic> which is upregulated in numerous types of cancer including lung cancer [<xref ref-type="bibr" rid="CR51">51</xref>]. The roles of calcium channels in various cell functions including mitogenesis, cell proliferation, differentiation, inflammation, and metastasis are well recognized [<xref ref-type="bibr" rid="CR52">52</xref>]. Through calmodulin, intracellular calcium (Ca<sup>2+</sup>) levels regulate many different kinases, phosphatases, cyclases, esterases, and ion channels. Increased intracellular Ca<sup>2+</sup> levels are correlated with cell proliferation, leading to inflammation and promoting carcinogenesis [<xref ref-type="bibr" rid="CR51">51</xref>]. Subjects with a higher BMI may have sufficient nutritional status, and current studies have demonstrated that people with higher intake of nutrients (e.g. high dietary calcium) can modulate circulating calcitriol, thereby regulating intracellular Ca<sup>2+</sup> levels [<xref ref-type="bibr" rid="CR53">53</xref>], maintaining the balance of intracellular and extracellular Ca<sup>2+</sup> concentrations and reducing the risk of lung cancer.</p>
              <p id="Par53">The SNP rs2336652, located near <italic>CLASP2</italic>, interacts with cytoplasmic linker protein, binds to microtubules, and has microtubule-stabilizing effects [<xref ref-type="bibr" rid="CR54">54</xref>]. Increasing microtubule instability may cause genetic instability, and altered expression of <italic>CLASP</italic>2 may induce genetic instability and contribute to the development of lung cancer [<xref ref-type="bibr" rid="CR55">55</xref>]. The variant rs79297227 is associated with the expression of <italic>SLC16A7</italic>. The <italic>SLC16A</italic> family of monocarboxylate transporters is a subfamily of solute carriers that transport monocarboxylate molecules, including L-lactate and pyruvate, across cell membranes [<xref ref-type="bibr" rid="CR56">56</xref>]. Aberrant expression of <italic>SLC16A</italic> gene family members occurs in various types of malignant tumours and regulates cell migration, invasion, and proliferation [<xref ref-type="bibr" rid="CR57">57</xref>–<xref ref-type="bibr" rid="CR59">59</xref>].</p>
              <p id="Par54">MR analysis revealed non-significant associations between genetic polymorphisms affecting BMI and NSCLC. Although MR is considered a powerful tool to infer causality from nature’s randomization, it cannot completely avoid bias and confounders; thus, the results of MR studies warrant a cautious interpretation [<xref ref-type="bibr" rid="CR60">60</xref>]. For example, BMI is strongly affected by smoking status, age, sex, and ethnicity [<xref ref-type="bibr" rid="CR61">61</xref>]. However, confounding could not result in the genetic variant, and it is possible that attenuation of a protective effect against NSCLC has been caused by adjustment for mediators actually along the causal pathway or associated with collider bias [<xref ref-type="bibr" rid="CR62">62</xref>]. In the end, the use of BMI variants in MR as proxies for BMI trajectories had inherent limitations due to the lack of previous GWAS studies on BMI trajectories, and insufficient PLCO genetic data despite the large sample in the PLCO cohort.</p>
              <p id="Par55">Our study had several strengths. First, this study was performed in a multi-centre, large sample size cohort. Second, we not only investigated the association between BMI trajectories and the NSCLC risk but also evaluated the interaction between BMI trajectories and genetic variants in the development of NSCLC. Third, we identified four novel and functionally plausible GWIA-based SNPs, which located near genes that paly critical roles in cell growth, differentiation, and inflammation and were mechanistically linked to BMI and NSCLC genesis. However, limitations of this study have also been identified. Similar to nearly all epidemiologic study on the subject, BMI at age 20 and 50 were obtained from individual’s self-report. However, that information was obtained before the subsequent development of the outcomes of interest, so recall bias could not have been operative. Second, a substantial number of exclusions could limit generalizability, while it constrained our study cohort to those with complete data available that should help mitigate against threats to internal validity. Third, residual for unmeasured confounding cannot be excluded even exhaustive adjustment was performed in the multivariable analyses. And conclusions from further Mendelian randomization, which purportedly provides a methodologic approach for causality inference, should also be treated with caution. Fourth, our findings have not been validated by other larger-sample epidemiological studies, especially the limited sample size of the PLCO GWAS data. Finally, additional functional studies are warranted to elucidate the mechanisms underlying the effects of these loci and BMI trajectories interactions on NSCLC risk.</p>
            </sec>
            <sec id="Sec12">
              <title>Conclusions</title>
              <p id="Par56">Our study found that genetic susceptibility may modify the effect of BMI trajectories on the development of NSCLC by regulating cell growth, differentiation and inflammation. Further larger or multi-ethnicity studies should be conducted to validate our findings.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec13">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="12916_2022_2400_MOESM1_ESM.docx">
                      <caption>
                        <p><bold>Additional file 1: Appendix S1.</bold> Supplementary methods. <bold>Table S1.</bold> Characteristics of the study subjects for GWAS. <bold>Table S2.</bold> Summary of the 19 GWAS-identified SNPs associated with lung cancer. <bold>Table S3.</bold> Association between age-specific BMI and NSCLC risk. <bold>Table S4.</bold> Sensitivity analysis for the association between BMI trajectory and NSCLC risk. <bold>Table S5.</bold> Association of <italic>s</italic>PRS<sub>GWAS</sub> and <italic>w</italic>PRS<sub>GWAS</sub> with NSCLC risk. <bold>Table S6.</bold> Interaction analysis between age-specific BMI and the <italic>s</italic>PRS<sub>GWAS</sub>. <bold>Table S7.</bold> Interaction analysis between age-specific BMI and the <italic>w</italic>PRS<sub>GWAS</sub>. <bold>Table S8.</bold> Summary of four independent SNPs identified by GWIA. <bold>Table S9.</bold> Sensitivity analyses for the interaction between BMI trajectory and rs79297227, rs2336652, rs16018 and rs79297227. <bold>Table S10.</bold> Single-nucleotide polymorphisms used as instrumental variables in the multivariable Mendelian randomization analyses of BMI trajectory. <bold>Table S11.</bold> Sensitivity analysis of the relationship between BMI trajectory and lung cancer using one-sample Mendelian randomization. <bold>Table S12.</bold> Interaction analysis between age-specific BMI/BMI trajectories and the <italic>s</italic>PRS<sub>GWIA</sub>. <bold>Table S13.</bold> Interaction analysis between age-specific BMI/BMI trajectories and the <italic>w</italic>PRS<sub>GWIA</sub>. <bold>Figure S1.</bold> Stratification analysis for age-specific BMI and BMI trajectory on NSCLC risk by sex. <bold>Figure S2.</bold> Stratification analysis for age-specific BMI and BMI trajectory on NSCLC risk by smoking status. <bold>Figure S3.</bold> Stratification analysis for age-specific BMI and BMI trajectory on NSCLC risk by histological type. <bold>Figure S4.</bold> Association of multivariate-adjusted NSCLC risk with BMI trajectories according to PRS<sub>GWIA</sub> categories. <bold>Figure S5.</bold> Circle Manhattan Plot for interaction analysis between SNPs and BMI trajectory in regard to NSCLC risk. <bold>Figure S6.</bold> Analysis of the four loci and related gene expression in lung tissue.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>BMI</term>
                  <def>
                    <p id="Par6">Body mass index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CI</term>
                  <def>
                    <p id="Par7">Confidence interval</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DNA</term>
                  <def>
                    <p id="Par8">Deoxyribonucleic acid</p>
                  </def>
                </def-item>
                <def-item>
                  <term>eQTL</term>
                  <def>
                    <p id="Par9">Expression quantitative trait loci</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GWAS</term>
                  <def>
                    <p id="Par10">Genome-wide association study</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GWIA</term>
                  <def>
                    <p id="Par11">Genome-wide interaction analysis</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HR</term>
                  <def>
                    <p id="Par12">Hazard ratio</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HWE</term>
                  <def>
                    <p id="Par13">Hardy-Weinberg equilibrium</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LD</term>
                  <def>
                    <p id="Par14">Linkage disequilibrium</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MAF</term>
                  <def>
                    <p id="Par15">Minor allele frequency</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MAPK</term>
                  <def>
                    <p id="Par16">Mitogen-activated protein kinase</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MR</term>
                  <def>
                    <p id="Par17">Mendelian randomization</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NSCLC</term>
                  <def>
                    <p id="Par18">Non-small cell lung cancer</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PLCO</term>
                  <def>
                    <p id="Par19">Prostate, lung, colorectal, and ovarian</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PRS</term>
                  <def>
                    <p id="Par20">Polygenic risk score</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PRS<sub>GWAS</sub></term>
                  <def>
                    <p id="Par21">Polygenic risk score constructed by 19 previous GWAS-identified SNPs</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PRS<sub>GWIA</sub></term>
                  <def>
                    <p id="Par22">Polygenic risk score constructed by 4 GWIA-identified SNPs</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SCLC</term>
                  <def>
                    <p id="Par23">Small cell lung cancer</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SD</term>
                  <def>
                    <p id="Par24">Standard deviation</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SNP</term>
                  <def>
                    <p id="Par25">Single nucleotide polymorphism</p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>s</italic>PRS</term>
                  <def>
                    <p id="Par26">Simple-count polygenic risk score</p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>s</italic>PRS<sub>GWAS</sub></term>
                  <def>
                    <p id="Par27">Simple-count polygenic risk score constructed by 19 previous GWAS-identified SNPs</p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>s</italic>PRS<sub>GWIA</sub></term>
                  <def>
                    <p id="Par28">Simple-count polygenic risk score constructed by 4 GWIA-identified SNPs</p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>w</italic>PRS</term>
                  <def>
                    <p id="Par29">Weighted polygenic risk score</p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>w</italic>PRS<sub>GWAS</sub></term>
                  <def>
                    <p id="Par30">Weighted polygenic risk score constructed by 19 previous GWAS-identified SNPs</p>
                  </def>
                </def-item>
                <def-item>
                  <term><italic>w</italic>PRS<sub>GWIA</sub></term>
                  <def>
                    <p id="Par31">Weighted polygenic risk score constructed by 4 GWIA-identified SNPs</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>David C. Christiani is the senior author who supervised the work.</p>
              </fn>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
              <fn>
                <p>Dongfang You, Danhua Wang, and Yaqian Wu contributed equally to this work.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>We thank all the PLCO study staff for their efforts and dedication to the study and acknowledge all the participants whose contributions made this project possible. We thank Mrs. Yue Wang for language polishing.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>D.Y., D.W., Y.W.1 (Yaqian Wu), F.C., and Y.Z. contributed to the study design. D.Y., X.C., and F.S. contributed to the data collection. D.Y., D.W., and Y.W.1 performed the statistical analyses and interpretation and drafted the manuscript. Y.Z., F.C., F.S., Y.W.2 (Yongyue Wei), R.Z., T.L., H.M., H.X., Z.H., D.C.C., and H.S. revised the manuscript. All authors contributed to the critical revision of the manuscript and approved its final version. Financial support and study supervision were provided by Y.Z. and F.C.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This work is supported by the National Natural Science Foundation of China [Project No. 82173620 to Y.Z., 81530088 to F.C., 81820108028 to H.S., 81922061 to H.M.], and US NIH/NCI [U01CA209414 to D.C.C], Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD).</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The PLCO phenotypic data and GWAS data analysed during the current study are available from the corresponding author on reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par57">This study was approved by the ethics committees of the PLCO consortium providers (PLCO-424) and approved by the ethics committees of Nanjing Medical University (Jiangsu, China). All patients provided written informed consent to participate in the study.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par58">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par59">The authors declare that they have no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rauscher</surname>
                      <given-names>GH</given-names>
                    </name>
                    <name>
                      <surname>Mayne</surname>
                      <given-names>ST</given-names>
                    </name>
                    <name>
                      <surname>Janerich</surname>
                      <given-names>DT</given-names>
                    </name>
                  </person-group>
                  <article-title>Relation between body mass index and lung cancer risk in men and women never and former smokers</article-title>
                  <source>Am J Epidemiol</source>
                  <year>2000</year>
                  <volume>152</volume>
                  <issue>6</issue>
                  <fpage>506</fpage>
                  <lpage>513</lpage>
                  <pub-id pub-id-type="doi">10.1093/aje/152.6.506</pub-id>
                  <?supplied-pmid 10997540?>
                  <pub-id pub-id-type="pmid">10997540</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Brinton</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Spitz</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Lam</surname>
                      <given-names>TK</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hollenbeck</surname>
                      <given-names>AR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Body mass index and risk of lung cancer among never, former, and current smokers</article-title>
                  <source>J Natl Cancer Inst</source>
                  <year>2012</year>
                  <volume>104</volume>
                  <issue>10</issue>
                  <fpage>778</fpage>
                  <lpage>789</lpage>
                  <pub-id pub-id-type="doi">10.1093/jnci/djs179</pub-id>
                  <?supplied-pmid 22457475?>
                  <pub-id pub-id-type="pmid">22457475</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bray</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ferlay</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Soerjomataram</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Siegel</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Torre</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Jemal</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>
                  <source>CA Cancer J Clin</source>
                  <year>2018</year>
                  <volume>68</volume>
                  <issue>6</issue>
                  <fpage>394</fpage>
                  <lpage>424</lpage>
                  <pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
                  <?supplied-pmid 30207593?>
                  <pub-id pub-id-type="pmid">30207593</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ettinger</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Wood</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Akerley</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Bazhenova</surname>
                      <given-names>LA</given-names>
                    </name>
                    <name>
                      <surname>Borghaei</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Camidge</surname>
                      <given-names>DR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Non-small cell lung cancer, Version 6.2015</article-title>
                  <source>J Natl Compr Cancer Netw</source>
                  <year>2015</year>
                  <volume>13</volume>
                  <issue>5</issue>
                  <fpage>515</fpage>
                  <lpage>524</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2015.0071</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alvarnas</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Alvarnas</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Obesity and cancer risk: a public health crisis</article-title>
                  <source>Am J Manag Care</source>
                  <year>2019</year>
                  <volume>25</volume>
                  <issue>11 Spec No.</issue>
                  <fpage>Sp332</fpage>
                  <lpage>Spsp3</lpage>
                  <?supplied-pmid 31860246?>
                  <pub-id pub-id-type="pmid">31860246</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ye</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Pan</surname>
                      <given-names>XF</given-names>
                    </name>
                    <name>
                      <surname>Pan</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study</article-title>
                  <source>BMJ</source>
                  <year>2019</year>
                  <volume>367</volume>
                  <fpage>l5584</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmj.l5584</pub-id>
                  <?supplied-pmid 31619383?>
                  <pub-id pub-id-type="pmid">31619383</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Zheng</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Johansson</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lan</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Overall and central obesity and risk of lung cancer: a pooled analysis</article-title>
                  <source>J Natl Cancer Inst</source>
                  <year>2018</year>
                  <volume>110</volume>
                  <issue>8</issue>
                  <fpage>831</fpage>
                  <lpage>842</lpage>
                  <pub-id pub-id-type="doi">10.1093/jnci/djx286</pub-id>
                  <?supplied-pmid 29518203?>
                  <pub-id pub-id-type="pmid">29518203</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duan</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Quan</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Yi</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Yuan</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis</article-title>
                  <source>Sci Rep</source>
                  <year>2015</year>
                  <volume>5</volume>
                  <fpage>16938</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep16938</pub-id>
                  <?supplied-pmid 26582414?>
                  <pub-id pub-id-type="pmid">26582414</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zheng</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Du</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Xin</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chu</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Ni</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort</article-title>
                  <source>Br J Cancer</source>
                  <year>2018</year>
                  <volume>119</volume>
                  <issue>1</issue>
                  <fpage>130</fpage>
                  <lpage>132</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41416-018-0121-y</pub-id>
                  <?supplied-pmid 29872147?>
                  <pub-id pub-id-type="pmid">29872147</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Petrick</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Kelly</surname>
                      <given-names>SP</given-names>
                    </name>
                    <name>
                      <surname>Liao</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Freedman</surname>
                      <given-names>ND</given-names>
                    </name>
                    <name>
                      <surname>Graubard</surname>
                      <given-names>BI</given-names>
                    </name>
                    <name>
                      <surname>Cook</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <article-title>Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies</article-title>
                  <source>Br J Cancer</source>
                  <year>2017</year>
                  <volume>116</volume>
                  <issue>7</issue>
                  <fpage>951</fpage>
                  <lpage>959</lpage>
                  <pub-id pub-id-type="doi">10.1038/bjc.2017.29</pub-id>
                  <?supplied-pmid 28196067?>
                  <pub-id pub-id-type="pmid">28196067</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <mixed-citation publication-type="other">Abdel-Rahman O. Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO trial. Expert Rev Respir Med. 2019:1–7.</mixed-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lichtenstein</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Holm</surname>
                      <given-names>NV</given-names>
                    </name>
                    <name>
                      <surname>Verkasalo</surname>
                      <given-names>PK</given-names>
                    </name>
                    <name>
                      <surname>Iliadou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kaprio</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Koskenvuo</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title>
                  <source>N Engl J Med</source>
                  <year>2000</year>
                  <volume>343</volume>
                  <issue>2</issue>
                  <fpage>78</fpage>
                  <lpage>85</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJM200007133430201</pub-id>
                  <?supplied-pmid 10891514?>
                  <pub-id pub-id-type="pmid">10891514</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brennan</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hainaut</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Boffetta</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetics of lung-cancer susceptibility</article-title>
                  <source>Lancet Oncol</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <issue>4</issue>
                  <fpage>399</fpage>
                  <lpage>408</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1470-2045(10)70126-1</pub-id>
                  <?supplied-pmid 20951091?>
                  <pub-id pub-id-type="pmid">20951091</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dai</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Wen</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population</article-title>
                  <source>Int J Cancer</source>
                  <year>2017</year>
                  <volume>140</volume>
                  <issue>2</issue>
                  <fpage>329</fpage>
                  <lpage>336</lpage>
                  <pub-id pub-id-type="doi">10.1002/ijc.30447</pub-id>
                  <?supplied-pmid 27668986?>
                  <pub-id pub-id-type="pmid">27668986</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sampson</surname>
                      <given-names>JN</given-names>
                    </name>
                    <name>
                      <surname>Wheeler</surname>
                      <given-names>WA</given-names>
                    </name>
                    <name>
                      <surname>Yeager</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Panagiotou</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Berndt</surname>
                      <given-names>SI</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types</article-title>
                  <source>J Natl Cancer Inst</source>
                  <year>2015</year>
                  <volume>107</volume>
                  <issue>12</issue>
                  <fpage>djv279</fpage>
                  <pub-id pub-id-type="doi">10.1093/jnci/djv279</pub-id>
                  <?supplied-pmid 26464424?>
                  <pub-id pub-id-type="pmid">26464424</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bosse</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Amos</surname>
                      <given-names>CI</given-names>
                    </name>
                  </person-group>
                  <article-title>A decade of GWAS results in lung cancer</article-title>
                  <source>Cancer Epidemiol Biomark Prev</source>
                  <year>2018</year>
                  <volume>27</volume>
                  <issue>4</issue>
                  <fpage>363</fpage>
                  <lpage>379</lpage>
                  <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-16-0794</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dai</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lv</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations</article-title>
                  <source>Lancet Respir Med</source>
                  <year>2019</year>
                  <volume>7</volume>
                  <issue>10</issue>
                  <fpage>881</fpage>
                  <lpage>891</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2213-2600(19)30144-4</pub-id>
                  <?supplied-pmid 31326317?>
                  <pub-id pub-id-type="pmid">31326317</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vineis</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Pearce</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Missing heritability in genome-wide association study research</article-title>
                  <source>Nat Rev Genet</source>
                  <year>2010</year>
                  <volume>11</volume>
                  <issue>8</issue>
                  <fpage>589</fpage>
                  <pub-id pub-id-type="doi">10.1038/nrg2809-c2</pub-id>
                  <?supplied-pmid 20634813?>
                  <pub-id pub-id-type="pmid">20634813</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Manuck</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>McCaffery</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Gene-environment interaction</article-title>
                  <source>Annu Rev Psychol</source>
                  <year>2014</year>
                  <volume>65</volume>
                  <fpage>41</fpage>
                  <lpage>70</lpage>
                  <pub-id pub-id-type="doi">10.1146/annurev-psych-010213-115100</pub-id>
                  <?supplied-pmid 24405358?>
                  <pub-id pub-id-type="pmid">24405358</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Malaiyandi</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Sellers</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Tyndale</surname>
                      <given-names>RF</given-names>
                    </name>
                  </person-group>
                  <article-title>Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence</article-title>
                  <source>Clinical Pharmacology &amp; Therapeutics</source>
                  <year>2005</year>
                  <volume>77</volume>
                  <issue>3</issue>
                  <fpage>145</fpage>
                  <lpage>158</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.clpt.2004.10.011</pub-id>
                  <pub-id pub-id-type="pmid">15735609</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oken</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Hocking</surname>
                      <given-names>WG</given-names>
                    </name>
                    <name>
                      <surname>Kvale</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Andriole</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Buys</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Church</surname>
                      <given-names>TR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial</article-title>
                  <source>Jama.</source>
                  <year>2011</year>
                  <volume>306</volume>
                  <issue>17</issue>
                  <fpage>1865</fpage>
                  <lpage>1873</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2011.1591</pub-id>
                  <?supplied-pmid 22031728?>
                  <pub-id pub-id-type="pmid">22031728</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gohagan</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Prorok</surname>
                      <given-names>PC</given-names>
                    </name>
                    <name>
                      <surname>Hayes</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Kramer</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Prostate</surname>
                      <given-names>LC</given-names>
                    </name>
                  </person-group>
                  <article-title>Ovarian Cancer Screening Trial Project T. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status</article-title>
                  <source>Control Clin Trials</source>
                  <year>2000</year>
                  <volume>21</volume>
                  <issue>6 Suppl</issue>
                  <fpage>251S</fpage>
                  <lpage>272S</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0197-2456(00)00097-0</pub-id>
                  <?supplied-pmid 11189683?>
                  <pub-id pub-id-type="pmid">11189683</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <mixed-citation publication-type="other">Kelly SP, Graubard BI, Andreotti G, Younes N, Cleary SD, Cook MB. Prediagnostic body mass index trajectories in relation to prostate cancer incidence and mortality in the PLCO Cancer Screening Trial. J Natl Cancer Inst. 2017;109(3).</mixed-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Armstrong</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Carraro</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Amanda</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Gaudreau</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Louvet</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <source>Latent class growth mdelling: a tutorial</source>
                  <year>2009</year>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koning</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hoekstra</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>de Jong</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Visscher</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Seidell</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Renders</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>Identifying developmental trajectories of body mass index in childhood using latent class growth (mixture) modelling: associations with dietary, sedentary and physical activity behaviors: a longitudinal study</article-title>
                  <source>BMC Public Health</source>
                  <year>2016</year>
                  <volume>16</volume>
                  <issue>1</issue>
                  <fpage>1128</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-016-3757-7</pub-id>
                  <?supplied-pmid 27793201?>
                  <pub-id pub-id-type="pmid">27793201</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lampousi</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Moller</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Berglind</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Forsell</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Latent class growth modelling for the evaluation of intervention outcomes: example from a physical activity intervention</article-title>
                  <source>J Behav Med</source>
                  <year>2021</year>
                  <volume>44</volume>
                  <issue>5</issue>
                  <fpage>622</fpage>
                  <lpage>629</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10865-021-00216-y</pub-id>
                  <?supplied-pmid 33768391?>
                  <pub-id pub-id-type="pmid">33768391</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nagin</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Odgers</surname>
                      <given-names>CL</given-names>
                    </name>
                  </person-group>
                  <article-title>Group-based trajectory modeling in clinical research</article-title>
                  <source>Annu Rev Clin Psychol</source>
                  <year>2010</year>
                  <volume>6</volume>
                  <fpage>109</fpage>
                  <lpage>138</lpage>
                  <pub-id pub-id-type="doi">10.1146/annurev.clinpsy.121208.131413</pub-id>
                  <?supplied-pmid 20192788?>
                  <pub-id pub-id-type="pmid">20192788</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tryka</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Hao</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Sturcke</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>ZY</given-names>
                    </name>
                    <name>
                      <surname>Ziyabari</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>NCBI’s Database of Genotypes and Phenotypes: dbGaP</article-title>
                  <source>Nucleic Acids Res</source>
                  <year>2014</year>
                  <volume>42</volume>
                  <issue>Database issue</issue>
                  <fpage>D975</fpage>
                  <lpage>D979</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkt1211</pub-id>
                  <?supplied-pmid 24297256?>
                  <pub-id pub-id-type="pmid">24297256</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mailman</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Feolo</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Kimura</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Tryka</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bagoutdinov</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The NCBI dbGaP database of genotypes and phenotypes</article-title>
                  <source>Nat Genet</source>
                  <year>2007</year>
                  <volume>39</volume>
                  <issue>10</issue>
                  <fpage>1181</fpage>
                  <lpage>1186</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng1007-1181</pub-id>
                  <?supplied-pmid 17898773?>
                  <pub-id pub-id-type="pmid">17898773</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huyghe</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Bien</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Harrison</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Schmit</surname>
                      <given-names>SL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Discovery of common and rare genetic risk variants for colorectal cancer</article-title>
                  <source>Nat Genet</source>
                  <year>2019</year>
                  <volume>51</volume>
                  <issue>1</issue>
                  <fpage>76</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41588-018-0286-6</pub-id>
                  <?supplied-pmid 30510241?>
                  <pub-id pub-id-type="pmid">30510241</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <mixed-citation publication-type="other">Wang ML, Gu DY, Du ML, Xu Z, Zhang SZ, Zhu LJ, et al. Common genetic variation in ETV6 is associated with colorectal cancer susceptibility. Nat Commun. 2016;7.</mixed-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Howie</surname>
                      <given-names>BN</given-names>
                    </name>
                    <name>
                      <surname>Donnelly</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Marchini</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>A flexible and accurate genotype imputation method for the next generation of genome-wide association studies</article-title>
                  <source>PLoS Genet</source>
                  <year>2009</year>
                  <volume>5</volume>
                  <issue>6</issue>
                  <fpage>e1000529</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pgen.1000529</pub-id>
                  <?supplied-pmid 19543373?>
                  <pub-id pub-id-type="pmid">19543373</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McKay</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Hung</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Zong</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Carreras-Torres</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Christiani</surname>
                      <given-names>DC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes</article-title>
                  <source>Nat Genet</source>
                  <year>2017</year>
                  <volume>49</volume>
                  <issue>7</issue>
                  <fpage>1126</fpage>
                  <lpage>1132</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.3892</pub-id>
                  <?supplied-pmid 28604730?>
                  <pub-id pub-id-type="pmid">28604730</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Vries</surname>
                      <given-names>PS</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Bentley</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Sung</surname>
                      <given-names>YJ</given-names>
                    </name>
                    <name>
                      <surname>Winkler</surname>
                      <given-names>TW</given-names>
                    </name>
                    <name>
                      <surname>Ntalla</surname>
                      <given-names>I</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Multiancestry genome-wide association study of lipid levels incorporating gene-alcohol interactions</article-title>
                  <source>Am J Epidemiol</source>
                  <year>2019</year>
                  <volume>188</volume>
                  <issue>6</issue>
                  <fpage>1033</fpage>
                  <lpage>1054</lpage>
                  <pub-id pub-id-type="doi">10.1093/aje/kwz005</pub-id>
                  <?supplied-pmid 30698716?>
                  <pub-id pub-id-type="pmid">30698716</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Battle</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Engelhardt</surname>
                      <given-names>BE</given-names>
                    </name>
                    <name>
                      <surname>Montgomery</surname>
                      <given-names>SB</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic effects on gene expression across human tissues</article-title>
                  <source>Nature.</source>
                  <year>2017</year>
                  <volume>550</volume>
                  <issue>7675</issue>
                  <fpage>204</fpage>
                  <lpage>213</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature24277</pub-id>
                  <?supplied-pmid 29022597?>
                  <pub-id pub-id-type="pmid">29022597</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Locke</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Kahali</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Berndt</surname>
                      <given-names>SI</given-names>
                    </name>
                    <name>
                      <surname>Justice</surname>
                      <given-names>AE</given-names>
                    </name>
                    <name>
                      <surname>Pers</surname>
                      <given-names>TH</given-names>
                    </name>
                    <name>
                      <surname>Day</surname>
                      <given-names>FR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic studies of body mass index yield new insights for obesity biology</article-title>
                  <source>Nature.</source>
                  <year>2015</year>
                  <volume>518</volume>
                  <issue>7538</issue>
                  <fpage>197</fpage>
                  <lpage>206</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature14177</pub-id>
                  <?supplied-pmid 25673413?>
                  <pub-id pub-id-type="pmid">25673413</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kundaje</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Meuleman</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Ernst</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bilenky</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Yen</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Heravi-Moussavi</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Integrative analysis of 111 reference human epigenomes</article-title>
                  <source>Nature.</source>
                  <year>2015</year>
                  <volume>518</volume>
                  <issue>7539</issue>
                  <fpage>317</fpage>
                  <lpage>330</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature14248</pub-id>
                  <?supplied-pmid 25693563?>
                  <pub-id pub-id-type="pmid">25693563</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ward</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Kellis</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease</article-title>
                  <source>Nucleic Acids Res</source>
                  <year>2016</year>
                  <volume>44</volume>
                  <issue>D1</issue>
                  <fpage>D877</fpage>
                  <lpage>D881</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkv1340</pub-id>
                  <?supplied-pmid 26657631?>
                  <pub-id pub-id-type="pmid">26657631</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grambsch</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Therneau</surname>
                      <given-names>TM</given-names>
                    </name>
                  </person-group>
                  <article-title>Proportional hazards tests and diagnostics based on weighted residuals</article-title>
                  <source>Biometrika</source>
                  <year>1994</year>
                  <volume>81</volume>
                  <issue>3</issue>
                  <fpage>515</fpage>
                  <lpage>526</lpage>
                  <pub-id pub-id-type="doi">10.1093/biomet/81.3.515</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hellstrom</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Nilsson</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>Wackernagel</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pivodic</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Vanpee</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sjobom</surname>
                      <given-names>U</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of enteral lipid supplement on severe retinopathy of prematurity: a randomized clinical trial</article-title>
                  <source>JAMA Pediatr</source>
                  <year>2021</year>
                  <volume>175</volume>
                  <issue>4</issue>
                  <fpage>359</fpage>
                  <lpage>367</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.5653</pub-id>
                  <?supplied-pmid 33523106?>
                  <pub-id pub-id-type="pmid">33523106</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lam</surname>
                      <given-names>VK</given-names>
                    </name>
                    <name>
                      <surname>Bentzen</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Mohindra</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Nichols</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Bhooshan</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Vyfhuis</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)</article-title>
                  <source>Lung Cancer</source>
                  <year>2017</year>
                  <volume>104</volume>
                  <fpage>52</fpage>
                  <lpage>57</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.lungcan.2016.11.017</pub-id>
                  <?supplied-pmid 28213000?>
                  <pub-id pub-id-type="pmid">28213000</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Greenlee</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Unger</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>LeBlanc</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ramsey</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hershman</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <article-title>Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials</article-title>
                  <source>Cancer Epidemiol Biomark Prev</source>
                  <year>2017</year>
                  <volume>26</volume>
                  <issue>1</issue>
                  <fpage>21</fpage>
                  <lpage>29</lpage>
                  <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-15-1336</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shepshelovich</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Body mass index (BMI), BMI change, and overall survival in patients with SCLC and NSCLC: a pooled analysis of the International Lung Cancer Consortium (Vol 14, pg 1594, 2019)</article-title>
                  <source>J Thorac Oncol</source>
                  <year>2019</year>
                  <volume>14</volume>
                  <issue>11</issue>
                  <fpage>2024</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.jtho.2019.09.003</pub-id>
                  <pub-id pub-id-type="pmid">31668320</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wood</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Jonsson</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Nagel</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Haggstrom</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Manjer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ulmer</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The inverse association of body mass index with lung cancer: exploring residual confounding, metabolic aberrations and within-person variability in smoking</article-title>
                  <source>Cancer Epidemiol Biomark Prev</source>
                  <year>2021</year>
                  <volume>30</volume>
                  <issue>8</issue>
                  <fpage>1489</fpage>
                  <lpage>1497</lpage>
                  <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-21-0058</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ross</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Ashley</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Norton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Priest</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Waters</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Eisen</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?</article-title>
                  <source>Br J Cancer</source>
                  <year>2004</year>
                  <volume>90</volume>
                  <issue>10</issue>
                  <fpage>1905</fpage>
                  <lpage>1911</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.bjc.6601781</pub-id>
                  <?supplied-pmid 15138470?>
                  <pub-id pub-id-type="pmid">15138470</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jamal-Hanjani</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>McGranahan</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Birkbak</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <name>
                      <surname>Watkins</surname>
                      <given-names>TBK</given-names>
                    </name>
                    <name>
                      <surname>Veeriah</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Tracking the evolution of non-small-cell lung cancer</article-title>
                  <source>N Engl J Med.</source>
                  <year>2017</year>
                  <volume>376</volume>
                  <issue>22</issue>
                  <fpage>2109</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1616288</pub-id>
                  <?supplied-pmid 28445112?>
                  <pub-id pub-id-type="pmid">28445112</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marchetti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Felicioni</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Malatesta</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Grazia Sciarrotta</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Guetti</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Chella</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations</article-title>
                  <source>J Clin Oncol</source>
                  <year>2011</year>
                  <volume>29</volume>
                  <issue>26</issue>
                  <fpage>3574</fpage>
                  <lpage>3579</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2011.35.9638</pub-id>
                  <?supplied-pmid 21825258?>
                  <pub-id pub-id-type="pmid">21825258</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Su</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Sui</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Pu</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms</article-title>
                  <source>Theranostics.</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <issue>15</issue>
                  <fpage>4461</fpage>
                  <lpage>4473</lpage>
                  <pub-id pub-id-type="doi">10.7150/thno.35219</pub-id>
                  <?supplied-pmid 31285773?>
                  <pub-id pub-id-type="pmid">31285773</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bost</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Aouadi</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Caron</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Binétruy</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of MAPKs in adipocyte differentiation and obesity</article-title>
                  <source>Biochimie.</source>
                  <year>2005</year>
                  <volume>87</volume>
                  <issue>1</issue>
                  <fpage>51</fpage>
                  <lpage>56</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biochi.2004.10.018</pub-id>
                  <?supplied-pmid 15733737?>
                  <pub-id pub-id-type="pmid">15733737</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tang</surname>
                      <given-names>QQ</given-names>
                    </name>
                    <name>
                      <surname>Grønborg</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Otto</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>Pandey</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis</article-title>
                  <source>Proc Natl Acad Sci U S A</source>
                  <year>2005</year>
                  <volume>102</volume>
                  <issue>28</issue>
                  <fpage>9766</fpage>
                  <lpage>9771</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.0503891102</pub-id>
                  <?supplied-pmid 15985551?>
                  <pub-id pub-id-type="pmid">15985551</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>CY</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Phan</surname>
                      <given-names>NN</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>YC</given-names>
                    </name>
                  </person-group>
                  <article-title>Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients</article-title>
                  <source>PLoS One</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <issue>7</issue>
                  <fpage>e0125766</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0125766</pub-id>
                  <?supplied-pmid 26147197?>
                  <pub-id pub-id-type="pmid">26147197</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lang</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Föller</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lang</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Lang</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Ritter</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Gulbins</surname>
                      <given-names>E</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ion channels in cell proliferation and apoptotic cell death</article-title>
                  <source>J Membr Biol</source>
                  <year>2005</year>
                  <volume>205</volume>
                  <issue>3</issue>
                  <fpage>147</fpage>
                  <lpage>157</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00232-005-0780-5</pub-id>
                  <?supplied-pmid 16362503?>
                  <pub-id pub-id-type="pmid">16362503</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zemel</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>SL</given-names>
                    </name>
                  </person-group>
                  <article-title>Dietary calcium and dairy modulation of adiposity and obesity risk</article-title>
                  <source>Nutr Rev</source>
                  <year>2004</year>
                  <volume>62</volume>
                  <issue>4</issue>
                  <fpage>125</fpage>
                  <lpage>131</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1753-4887.2004.tb00034.x</pub-id>
                  <?supplied-pmid 15141427?>
                  <pub-id pub-id-type="pmid">15141427</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Akhmanova</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hoogenraad</surname>
                      <given-names>CC</given-names>
                    </name>
                    <name>
                      <surname>Drabek</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Stepanova</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Dortland</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Verkerk</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Clasps are CLIP-115 and -170 associating proteins involved in the regional regulation of microtubule dynamics in motile fibroblasts</article-title>
                  <source>Cell.</source>
                  <year>2001</year>
                  <volume>104</volume>
                  <issue>6</issue>
                  <fpage>923</fpage>
                  <lpage>935</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00288-4</pub-id>
                  <?supplied-pmid 11290329?>
                  <pub-id pub-id-type="pmid">11290329</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tai</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Mak</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>PK</given-names>
                    </name>
                    <name>
                      <surname>Chua</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers</article-title>
                  <source>Cancer Res</source>
                  <year>2006</year>
                  <volume>66</volume>
                  <issue>8</issue>
                  <fpage>4133</fpage>
                  <lpage>4138</lpage>
                  <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2775</pub-id>
                  <?supplied-pmid 16618734?>
                  <pub-id pub-id-type="pmid">16618734</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Halestrap</surname>
                      <given-names>AP</given-names>
                    </name>
                  </person-group>
                  <article-title>The SLC16 gene family – structure, role and regulation in health and disease</article-title>
                  <source>Mol Asp Med</source>
                  <year>2013</year>
                  <volume>34</volume>
                  <issue>2-3</issue>
                  <fpage>337</fpage>
                  <lpage>349</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mam.2012.05.003</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Dong</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Guan</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>MCT1 regulates aggressive and metabolic phenotypes in bladder cancer</article-title>
                  <source>J Cancer</source>
                  <year>2018</year>
                  <volume>9</volume>
                  <issue>14</issue>
                  <fpage>2492</fpage>
                  <lpage>2501</lpage>
                  <pub-id pub-id-type="doi">10.7150/jca.25257</pub-id>
                  <?supplied-pmid 30026847?>
                  <pub-id pub-id-type="pmid">30026847</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>ZL</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>miR-124 suppresses pancreatic ductal adenocarcinoma growth by regulating monocarboxylate transporter 1-mediated cancer lactate metabolism</article-title>
                  <source>Cell Physiol Biochem</source>
                  <year>2018</year>
                  <volume>50</volume>
                  <issue>3</issue>
                  <fpage>924</fpage>
                  <lpage>935</lpage>
                  <pub-id pub-id-type="doi">10.1159/000494477</pub-id>
                  <?supplied-pmid 30355947?>
                  <pub-id pub-id-type="pmid">30355947</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanità</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Capulli</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Teti</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Galatioto</surname>
                      <given-names>GP</given-names>
                    </name>
                    <name>
                      <surname>Vicentini</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Chiarugi</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression</article-title>
                  <source>BMC Cancer</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>154</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2407-14-154</pub-id>
                  <?supplied-pmid 24597899?>
                  <pub-id pub-id-type="pmid">24597899</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Hoffmann</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Nah</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Vittinghoff</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Delling</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Marcus</surname>
                      <given-names>GM</given-names>
                    </name>
                  </person-group>
                  <article-title>Coffee consumption and incident tachyarrhythmias reported behavior, Mendelian randomization, and their interactions</article-title>
                  <source>JAMA Intern Med</source>
                  <year>2021</year>
                  <volume>181</volume>
                  <issue>9</issue>
                  <fpage>1185</fpage>
                  <lpage>1193</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamainternmed.2021.3616</pub-id>
                  <?supplied-pmid 34279564?>
                  <pub-id pub-id-type="pmid">34279564</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hales</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Fryar</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Carroll</surname>
                      <given-names>MD</given-names>
                    </name>
                    <name>
                      <surname>Freedman</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Aoki</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Ogden</surname>
                      <given-names>CL</given-names>
                    </name>
                  </person-group>
                  <article-title>Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013-2016</article-title>
                  <source>Jama-Journal of the American Medical Association</source>
                  <year>2018</year>
                  <volume>319</volume>
                  <issue>23</issue>
                  <fpage>2419</fpage>
                  <lpage>2429</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2018.7270</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <mixed-citation publication-type="other">Cornelis MC, Munafo MR. Mendelian randomization studies of coffee and caffeine consumption. Nutrients. 2018;10(10).</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
